Another TF, ZNF778, was also a strong predictor of regorafenib cell viability (Fig. 2B, Additional file 1: Fig. S1); the ZNF778 promoter has also been found to be highly mutated in melanoma [72]. This evidence concerns the gene TF and melanoma.